Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00624364

Femme et Homme

Extrait

This trial is conducted in Africa. The aim of this trial is to evaluate the efficacy and safety of biphasic insulin aspart plus OAD compared to biphasic insulin aspart alone on blood glucose control in type 2 diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2

Liens